May also explain why the US listing strategy (possible partner etc.) was deferred until June. The award of this patient could not only effect any proposed valuation but also who may want and who Biota might want to partner with.
Regards
SP
BTA Price at posting:
79.0¢ Sentiment: Hold Disclosure: Held